FRA:BAYN - Bayer Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started €68.07 +0.17 (+0.25 %) (As of 02/22/2019 05:11 AM ET)Previous Close€67.90Today's Range€67.68 - €68.2452-Week Range€91.58 - €123.82Volume277,686 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. Bayer Aktiengesellschaft has a collaboration agreement with The University of Texas MD Anderson Cancer Center to develop cancer treatments, as well as Haplogen GmbH. The company was founded in 1863 and is headquartered in Leverkusen, Germany. Receive BAYN News and Ratings via Email Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange FRA Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolFRA:BAYN Previous Symbol CUSIPN/A CIKN/A Webwww.bayer.de Phone+49-214-301Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees118,196 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Bayer (FRA:BAYN) Frequently Asked Questions What is Bayer's stock symbol? Bayer trades on the FRA under the ticker symbol "BAYN." What price target have analysts set for BAYN? 24 analysts have issued 1 year price targets for Bayer's stock. Their predictions range from €69.00 to €123.00. On average, they expect Bayer's share price to reach €88.37 in the next twelve months. This suggests a possible upside of 29.8% from the stock's current price. View Analyst Price Targets for Bayer. What is the consensus analysts' recommendation for Bayer? 24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 7 hold ratings and 17 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bayer. Has Bayer been receiving favorable news coverage? Media stories about BAYN stock have trended positive recently, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bayer earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned news stories about the healthcare company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the stock's share price in the next several days. Who are some of Bayer's key competitors? Some companies that are related to Bayer include Allergy Therapeutics (AGY), BEXIMCO PHARMAC/S GDR REGS (BXP), Cathay International (CTI), Dechra Pharmaceuticals (DPH), Eco Animal Health Group (EAH), Futura Medical (FUM), Hutchison China MediTech (HCM), N4 Pharma (N4P), OTSUKA HOLDINGS/ADR (OTSKY), Sanofi (SAN), Sareum (SAR), SINR PHAR/PAR VTG FPD 0.01 (SPH) and Vectura Group (VEC). What other stocks do shareholders of Bayer own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer investors own include Hawkins (HWKN), CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Micron Technology (MU), Accenture (ACN), Honeywell International (HON), Athabasca Oil (ATH) and Alibaba Group (BABA). Who are Bayer's key executives? Bayer's management team includes the folowing people: Mr. Werner Baumann, Chairman of Management & CEO (Age 57)Mr. Liam Condon, CEO & Pres of Bayer Cropscience and Member of Management Board (Age 51)Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)Dr. Hartmut Klusik, Head of HR, Technology & Sustainability and Member of Management Board (Age 63)Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50) What is Bayer's stock price today? One share of BAYN stock can currently be purchased for approximately €68.07. What is Bayer's official website? The official website for Bayer is https://www.bayer.de/. How can I contact Bayer? Bayer's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301. MarketBeat Community Rating for Bayer (FRA BAYN)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 1,329 (Vote Outperform)Underperform Votes: 849 (Vote Underperform)Total Votes: 2,178MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2019 by MarketBeat.com StaffFeatured Article: What is a stock buyback?